MEDraysintell releases its first Nuclear Medicine Market Essentials report

MEDraysintell publishes its new “Nuclear Medicine Market Essentials” report providing key facts and figures on Nuclear Medicine to advice non-industry insiders on the potential for investments, merger and acquisitions (M&A), technology and market development existing in this healthcare technology.

This “Nuclear Medicine Market Essentials” report will be a real asset for the healthcare industry or for the financial community (investors, investment bankers and M&A professionals) to support their audit and to make informed decisions with unbiased and factual intelligence from experts.

This condensed report, with over 40 tables and figures, provides the most accurate and up-to-date information (status by end of 2016) related to the nuclear medicine industry. It includes important insights on the market, key drivers, vendors, products (radiodiagnostics and radiotherapeutics) of interest for the coming decade, as well as companies to monitor, mostly in tabulated forms with the most recent and precise figures and names. It covers not only radiopharmaceuticals, but also equipment (cyclotrons and cameras), as well as some aspects of the brachytherapy market sometimes overlapping with the nuclear medicine specialty (microspheres and seeds).

The report is available at the price of EUR 850.
Contact Paul-Emmanuel Goethals for information and to order:
peg@medraysintell.com or +32 491 080 968

MEDraysintell believes it is the right moment to publish such a “Market Essentials” report as nuclear medicine has entered an era of high potential for growth, involving new technologies and a high number of products close to being marketed or under advanced stage development. This business will trigger the interest of new investors as well as the conventional pharmaceutical industry to support these markets which are rising up to three times faster than the global healthcare market.

MEDraysintell has already supported numerous companies globally helping them to better understand these markets, and welcomes your requests for specific intelligence needs in these areas.

About MEDraysintell
Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors!

MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy.
We offer the most comprehensive set of reports and directories, with over 1,900 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts. We are proud to support numerous companies globally, helping them better understand the markets, competitive environment as well as the potential of merger and acquisitions (M&A) and technology development. We have repeat satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories.
MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines over 40 years of experience in radiation healthcare. www.medraysintell.com

Paul-Emmanuel Goethals, MBA
Louvain-la-Neuve, Belgium
peg@medraysintell.com
Mobile: +32 491 080 968

Richard Zimmermann, PhD
Lalaye, France
rz@medraysintell.com
Mobile: +33 6 82 80 06 00

This release was published on openPR.